Disease modifying drug therapy
This version published May 2007
This booklet aims to provide basic information about the currently available disease modifying drug therapies. It is designed to answer some of the questions you may have about whether or not these treatments are suitable for you, whether you decide to start these drugs, and how you go about taking them.
This booklet supports but cannot replace the personal advice that a neurologist and MS specialist nurse can give you about your individual circumstances.
- Contents
- What are disease modifying drugs and what do they do?
- What drugs are available?
- More information about beta interferons and glatiramer acetate
- Making the decision: practical considerations
- Prescribing guidelines for beta interferon and glatiramer acetate
- Prescribing centres for beta interferon and glatiramer acetate
Acknowledgments
Thank you to the following reviewers:
- the people with MS who reviewed this book
- the representatives from the pharmaceutical manufacturers
- Emily Harrison, Stephanie Heath, Elizabeth Keenan, MS specialist nurses
National Hospital for Neurology and Neurosurgery, London; - Jane Ware, MS specialist nurse
Wessex Neuroscience Centre, Southampton; - Nikki Embrey, clinical nurse specialist - MS
North Staffordshire University Hospital, Stoke-on-Trent.
The MS Trust Information Service is happy to supply information about MS for employers and colleagues at work.
